Bemcentinib

Generic Name
Bemcentinib
Brand Names
-
Drug Type
Small Molecule
Chemical Formula
C30H34N8
CAS Number
1037624-75-1
Unique Ingredient Identifier
0ICW2LX8AS
Background

Bemcentinib has been investigated for the treatment of Non-Small Cell Lung Cancer.

Associated Conditions
-
Associated Therapies
-
contractpharma.com
·

BerGenBio Names New CEO

BerGenBio ASA appoints Olav Hellebø as CEO, leveraging his 30 years of experience in pharmaceuticals and biotechnology, including roles at ReNeuron Group PLC and Clavis Pharma ASA. Hellebø aims to advance BerGenBio's candidate drug, bemcentinib, for non-squamous non-small cell lung cancer with STK11 mutations.
© Copyright 2024. All Rights Reserved by MedPath